Newcastle researchers have revealed the first treatment to target the underlying cause of a rare kidney condition called "C3G ...
Newcastle researchers have revealed the first treatment to target the underlying cause of a rare kidney condition called “C3G ...
During the last three months, 12 analysts shared their evaluations of Apellis Pharmaceuticals (NASDAQ: APLS), revealing diverse outlooks from bullish to bearish. The table below summarizes their ...
12hon MSN
Man with 'ultra-rare' kidney disease finally has hope for future after pioneering Newcastle research
James Mason feels "empowered" thanks to his involvement in a pioneering clinical trial to find a treatment for a rare kidney ...
Medindia on MSN
Oral Bacteria May Be the Hidden Trigger Behind Heart Attacks
Oral bacteria viridans streptococci were found in over 60 percent of arterial plaques Biofilm-forming bacteria in plaque ...
Need a solution for a flaky, dry scalp? We spoke to 8 doctors on the best dandruff shampoos that really work and won't leave ...
Colette Matz, country president of Novartis Hungary, talks about the potentially lifesaving clinical trials they run in ...
Bacteria are constantly moving with the help of motility organs called flagella or pili to colonize new niches. Also, ...
The innate immune system sees drugs as threats, but researchers are taking advantage of this response to make cancer therapies more effective.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback